ABSCI CORP Long-Term Debt, Maturity, Remainder of Fiscal Year
ABSCI CORP (ABSI) had Long-Term Debt, Maturity, Remainder of Fiscal Year of $754.00 thousand as of 2022-09-30, per its 10-Q filed 2022-11-09.
Discontinued › Notes › Commitment and Contingencies
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear · last filed 2022-11-09
- 2022-09-30: Long-Term Debt, Maturity, Remainder of Fiscal Year $754.00K.
- 2022-06-30: Long-Term Debt, Maturity, Remainder of Fiscal Year $1.34M.
| Period end | Long-Term Debt, Maturity, Remainder of Fiscal Year |
|---|---|
| 2022-09-30 | $754.00K 10-Q · filed 2022-11-09 |
| 2022-06-30 | $1.34M 10-Q · filed 2022-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |